Taclink released an announcement revealing that the cumulative rise in the company's stock closing prices over three consecutive trading days surpassed 30%, indicating abnormal stock trading fluctuations. On March 31, 2026, the company conducted a conference call to provide a performance overview of its 2025 annual report. Addressing investors' inquiries regarding the progress, technical blueprint, and future strategies for OCS products, the company clarified that currently, OCS products remain in the prototype phase. Given the substantial overall investment and their nascent stage of development, these products have not been factored into the financial budgets and performance plans for the upcoming two to three years.
